| Estimating the effectiveness of DPYD genotyping in Italian individuals suffering from cancer based on the cost of chemotherapy-induced toxicity V Fragoulakis, R Roncato, C Dalle Fratte, F Ecca, M Bartsakoulia, ... The American Journal of Human Genetics 104 (6), 1158-1168, 2019 | 50 | 2019 |
| The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice G Toffoli, F Innocenti, J Polesel, E De Mattia, F Sartor, C Dalle Fratte, ... Clinical Pharmacology & Therapeutics 105 (4), 994-1002, 2019 | 46 | 2019 |
| Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation E Cecchin, E De Mattia, F Ecca, G Toffoli Drug Resistance Updates 39, 18-40, 2018 | 32 | 2018 |
| Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk E De Mattia, M Silvestri, J Polesel, F Ecca, S Mezzalira, L Scarabel, ... Biomedicine & Pharmacotherapy 154, 113644, 2022 | 30 | 2022 |
| Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects C Russo Spena, L De Stefano, G Poli, C Granchi, M El Boustani, F Ecca, ... Journal of Cellular Physiology 234 (9), 15708-15716, 2019 | 30 | 2019 |
| Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer … M Garziera, E Cecchin, G Giorda, R Sorio, S Scalone, E De Mattia, ... Cells 8 (10), 1186, 2019 | 15 | 2019 |
| DPYD Gene Activity Score Predicts Dose-Limiting Toxicity in Fluoropyrimidine-Treated Colorectal Cancer Patients C Dalle Fratte, J Polesel, R Roncato, E De Mattia, F Ecca, A Bignucolo, ... Journal of Molecular and Clinical Medicine 1 (3), 143-150, 2018 | 12 | 2018 |
| The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines E De Mattia, R Roncato, C Dalle Fratte, F Ecca, G Toffoli, E Cecchin Cancer Drug Resistance 2 (1), 116, 2019 | 7 | 2019 |
| Immunogenetics of prostate cancer: a still unexplored field of study E Dreussi, F Ecca, L Scarabel, S Gagno, G Toffoli Pharmacogenomics 19 (3), 263-283, 2018 | 7 | 2018 |
| PHARMACOGENETICS OF FLUOROPYRIMIDINES: FROM THE IMPLEMENTATION OF GUIDELINES TO IDENTIFICATION OF NOVEL GERMLINE VARIANTS RELATED TO TOXICITY F Ecca Università degli Studi di Udine, 2020 | | 2020 |
| Next-Generation Sequencing to Identify Rare Variants Related to FL-Toxicity F Ecca, E De Mattia, F Serra, R Roncato, E Dreussi, L Romanato, ... PUBLIC HEALTH GENOMICS 21, 19-19, 2018 | | 2018 |
